It is clear that correct attachment of sialic acids is essential to a diverse array of physiologically significant events. Quantitatively and qualitatively correct sialylation requires precise orchestration in the expression of the cognate sialyltransferases. Recent efforts by a number of laboratories have resulted in the molecular cloning of a number of sialyltransferases. However, the molecular pathways that dictate the expression of these sialyltransferases remain mostly unknown. Past and current effort from this laboratory have been devoted to elucidating the gene structure of one of these sialyltransferases, the beta-galactoside alpha2,6-sialyltransferase (SIAT1), and the regulation of its expression. The experiments proposed here are a continuation of these studies. The eventual goal is an in-depth understanding of the regulatory pathways controlling SIAT1 expression. The initial aims will be to establish, by means of cell transfection assays, genetic sequences required for tissue- and cellular-specificity in SIAT1 expression. Putative regulatory sequences will be tested in vivo by mean of transgene fusion constructs containing reporter sequences. Finally, experiments are proposed that will utilize the recently established technology to generate mutant strains of mice using homologous recombination in embryonic stem cells. This will allow unprecedented in vivo studies addressing issues concerning not only regulation, but also functional contributions of sialyltransferase expression in different tissues. Experiments are also proposed to initiate a similar analysis on the beta- galactoside alpha2,3-sialyltransferases (SIAT4). Three distinct enzymes encoded on separate genes are competent in the elaboration of the SIAT4 sialyl- linkage. As with the proposed studies on SIAT1, these initial studies will address the molecular basis and regulation of expression of the SIAT4 genes. Later, if time permits, experiments will be directed at understanding the significance of multiple SIAT4 genes, and functional differences, if any, of the SIAT4s.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM038193-12
Application #
2734565
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1987-04-01
Project End
2000-06-30
Budget Start
1998-07-01
Budget End
2000-06-30
Support Year
12
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Appenheimer, Michelle M; Huang, Ruea-Yea; Chandrasekaran, E V et al. (2003) Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase. Glycobiology 13:591-600
Wuensch, S A; Huang, R Y; Ewing, J et al. (2000) Murine B cell differentiation is accompanied by programmed expression of multiple novel beta-galactoside alpha2, 6-sialyltransferase mRNA forms. Glycobiology 10:67-75
Lo, N W; Dennis, J W; Lau, J T (1999) Overexpression of the alpha2,6-sialyltransferase, ST6Gal I, in a low metastatic variant of a murine lymphoblastoid cell line is associated with appearance of a unique ST6Gal I mRNA. Biochem Biophys Res Commun 264:619-21
Dalziel, M; Lemaire, S; Ewing, J et al. (1999) Hepatic acute phase induction of murine beta-galactoside alpha 2,6 sialyltransferase (ST6Gal I) is IL-6 dependent and mediated by elevation of exon H-containing class of transcripts. Glycobiology 9:1003-8
Lo, N W; Lau, J T (1999) Transcription of the beta-galactoside alpha2,6-sialyltransferase gene (SIAT1) in B-lymphocytes: cell type-specific expression correlates with presence of the divergent 5'-untranslated sequence. Glycobiology 9:907-14
Dimitroff, C J; Pera, P; Dall'Olio, F et al. (1999) Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells. Biochem Biophys Res Commun 256:631-6
Dall'Olio, F; Chiricolo, M; Lau, J T (1999) Differential expression of the hepatic transcript of beta-galactoside alpha2,6-sialyltransferase in human colon cancer cell lines. Int J Cancer 81:243-7
Kalcheva, I; Elliott, R W; Dalziel, M et al. (1997) The gene encoding beta-galactoside alpha2,6-sialyltransferase maps to mouse chromosome 16. Mamm Genome 8:619-20
Hu, Y P; Dalziel, M; Lau, J T (1997) Murine hepatic beta-galactoside alpha 2,6-sialyltransferase gene expression involves usage of a novel upstream exon region. Glycoconj J 14:407-11
Dall'Olio, F; Mariani, E; Tarozzi, A et al. (1997) Expression of beta-galactoside alpha 2,6-sialyltransferase does not alter the susceptibility of human colon cancer cells to NK-mediated cell lysis. Glycobiology 7:507-13

Showing the most recent 10 out of 24 publications